Status:
RECRUITING
New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
BK Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
BK virus (BKV) infection has a major negative impact on transplant recipients. No BKV-specific antiviral therapy is available, so there is an urgent need to develop new anti-BKV preventive and therape...
Eligibility Criteria
Inclusion
- BK positive
- adult
- ok to participed to research
Exclusion
- under guardianship
- under curatorship
- opposed to research
- deprived of liberty
Key Trial Info
Start Date :
September 5 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05264259
Start Date
September 5 2022
End Date
December 1 2025
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Virologie - CHU Strasbourg - France
Strasbourg, France, 67091